Landos Biopharma Inc
Biotechnology
Healthcare
LABP
6.21 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
3.75
52 week high
15.00
high
4.53
52 week low
1.34
low
3.75
growth
49.48 %
previous Close
3.66
P/E ratio
market cap
12.44 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-3.92 M
29.83 %
eps
0.00 %
-600.00 %
eps surprise
42.73 %
net profit margin
-392200000.00 %
0.00 %
operating incoming
-4.44 M
31.49 %
net change in cash
-1.20 M
-113.89 %
cash on hand
44.05 M
-2.64 %
cost of revenue
0.00 %
top top